Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): Preclinical development and application to the treatment of Parkinson's disease

被引：51

作者：

Lapchak, PA

Gash, DM

Collins, F

Hilt, D

Miller, PJ

Araujo, DM

机构：

[1] AMGEN INC, DEPT NEUROSCI, THOUSAND OAKS, CA 91320 USA

[2] AMGEN INC, DEPT CLIN DEV, THOUSAND OAKS, CA 91320 USA

[3] UNIV KENTUCKY, DEPT ANAT & NEUROBIOL, LEXINGTON, KY 40536 USA

来源：

EXPERIMENTAL NEUROLOGY | 1997年 / 145卷 / 02期

关键词：

D O I：

10.1006/exnr.1997.6501

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

[No abstract available]

引用

页码：309 / 321

页数：13

共 65 条

[41]

Marsden C.D., 1982, Movement Disorders, V2, P96

[42] ON-OFF EFFECTS IN PATIENTS WITH PARKINSONS-DISEASE ON CHRONIC LEVODOPA THERAPY [J].

MARSDEN, CD ;

PARKES, JD .

LANCET, 1976, 1 (7954) :292-296

[43] Glial cell line-derived neurotrophic factor: The lateral cerebral ventricle as a site of administration for stimulation of the substantia nigra dopamine system in rats [J].

Martin, D ;

Miller, G ;

Fischer, N ;

Dix, D ;

Cullen, T ;

Russell, D .

EUROPEAN JOURNAL OF NEUROSCIENCE, 1996, 8 (06) :1249-1255

[44]

Miller G., 1994, Society for Neuroscience Abstracts, V20, P1300

[45]

MIYOSHI Y, 1997, IN PRESS ANN NEUROL

[46] GLIAL-CELL LINE-DERIVED NEUROTROPHIC FACTOR PROMOTES THE SURVIVAL AND MORPHOLOGIC DIFFERENTIATION OF PURKINJE-CELLS [J].

MOUNT, HTJ ;

DEAN, DO ;

ALBERCH, J ;

DREYFUS, CF ;

BLACK, IB .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9092-9096

[47]

OpackaJuffry J, 1995, NEUROREPORT, V7, P348

[48]

OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321

[49] NEURONAL BASIS OF THE PARKINSONIAN RESTING TREMOR - A HYPOTHESIS AND ITS IMPLICATIONS FOR TREATMENT [J].

PARE, D ;

DOSSI, RC ;

STERIADE, M .

NEUROSCIENCE, 1990, 35 (02) :217-226

[50]

PENNEY JB, 1992, PRINCIPLES DRUG THER

← 1 2 3 4 5 6 7 →